Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Prediagnosis Insights Into Amyotrophic Lateral Sclerosis: Clinical Symptoms and Medication Use

by jlohrconsulting | Jul 11, 2025 | Uncategorized

J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70003. doi: 10.1002/jcsm.70003. ABSTRACT BACKGROUND: Amyotrophic lateral sclerosis (ALS) has a prolonged latency period, though its preclinical characteristics remain poorly understood. This study uses UK Biobank data to...

Do we need novel treatments for anorexia nervosa? A patient perspective

by jlohrconsulting | Jul 11, 2025 | Uncategorized

Br J Psychiatry. 2025 Jul 11:1-5. doi: 10.1192/bjp.2025.10314. Online ahead of print. ABSTRACT Despite growing interest in novel treatments for anorexia nervosa, outcomes remain poor – often not because existing interventions are inherently ineffective, but due...

Exploring the Interplay Between Thyroid Hormone Levels and Symptoms of Anxiety and Depression in Anorexia Nervosa

by jlohrconsulting | Jul 11, 2025 | Uncategorized

Brain Behav. 2025 Jul;15(7):e70685. doi: 10.1002/brb3.70685. ABSTRACT OBJECTIVE: A strong association exists between anorexia nervosa (AN) and symptoms of depression, anxiety, and obsessive-compulsive disorder (OCD). The levels of these psychiatric symptoms observed...

Inflammatory links between epilepsy and depression: a review of mechanisms and therapeutic strategies

by jlohrconsulting | Jul 11, 2025 | Uncategorized

Front Neurosci. 2025 Jun 26;19:1614297. doi: 10.3389/fnins.2025.1614297. eCollection 2025. ABSTRACT Depression is the most common psychiatric comorbidity of epilepsy. While antiseizure medications (ASMs) can exacerbate depressive symptoms, depression itself may...

Validating the antiseizure effects of vitexin and related flavone glycosides in zebrafish

by jlohrconsulting | Jul 11, 2025 | Uncategorized

Front Pharmacol. 2025 Jun 26;16:1628324. doi: 10.3389/fphar.2025.1628324. eCollection 2025. ABSTRACT Current epilepsy treatments often fail to provide sufficient control over seizures, highlighting the need for new therapeutic agents. Vitexin, a flavone with...

Fractionated stereotactic radiotherapy in people with drug-resistant focal epilepsy: first-in-human experience with a healthy tissue-preserving dose-fractionation concept

by jlohrconsulting | Jul 11, 2025 | Uncategorized

Front Neurol. 2025 Jun 26;16:1600381. doi: 10.3389/fneur.2025.1600381. eCollection 2025. ABSTRACT OBJECTIVE: Stereotactic radiosurgery (SRS) emerges as a non-surgical treatment option for drug-resistant non-neoplastic focal epilepsy. Previous studies have reported...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments